-
Je něco špatně v tomto záznamu ?
Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4'-C-methylribonucleosides
P. Nauš, O. Caletková, P. Perlíková, L. Poštová Slavětínská, E. Tloušťová, J. Hodek, J. Weber, P. Džubák, M. Hajdúch, M. Hocek,
Bioorganic & medicinal chemistry.
2015 ;
23 (23) :
7422-38.
[pub] 20151031
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Perzistentní odkaz
https://www.medvik.cz/link/bmc16027970
- MeSH
- antitumorózní látky chemická syntéza farmakologie MeSH
- antivirové látky chemická syntéza farmakologie MeSH
- Hepacivirus účinky léků MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- prekurzory léčiv chemická syntéza farmakologie MeSH
- purinové nukleosidy chemická syntéza farmakologie MeSH
- purinové nukleotidy chemická syntéza farmakologie MeSH
- virus dengue účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The synthesis and biological activity profiling of a large series of diverse pyrrolo[2,3-d]pyrimidine 4'-C-methylribonucleosides bearing an (het)aryl group at position 4 or 5 is reported as well as the synthesis of several phosphoramidate prodrugs. These compounds are 4'-C-methyl derivatives of previously reported cytostatic hetaryl-7-deazapurine ribonucleosides. The synthesis is based on glycosylation of halogenated 7-deazapurine bases with 1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-methyl-β-d-ribofuranose followed by cross-coupling and nucleophilic substitution reactions. The final compounds showed low cytotoxicity and several derivatives exerted antiviral activity against HCV or Dengue viruses at micromolar concentrations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16027970
- 003
- CZ-PrNML
- 005
- 20161021095520.0
- 007
- ta
- 008
- 161005s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bmc.2015.10.040 $2 doi
- 024 7_
- $a 10.1016/j.bmc.2015.10.040 $2 doi
- 035 __
- $a (PubMed)26558518
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nauš, Petr $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 245 10
- $a Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4'-C-methylribonucleosides / $c P. Nauš, O. Caletková, P. Perlíková, L. Poštová Slavětínská, E. Tloušťová, J. Hodek, J. Weber, P. Džubák, M. Hajdúch, M. Hocek,
- 520 9_
- $a The synthesis and biological activity profiling of a large series of diverse pyrrolo[2,3-d]pyrimidine 4'-C-methylribonucleosides bearing an (het)aryl group at position 4 or 5 is reported as well as the synthesis of several phosphoramidate prodrugs. These compounds are 4'-C-methyl derivatives of previously reported cytostatic hetaryl-7-deazapurine ribonucleosides. The synthesis is based on glycosylation of halogenated 7-deazapurine bases with 1,2-di-O-acetyl-3,5-di-O-benzyl-4-C-methyl-β-d-ribofuranose followed by cross-coupling and nucleophilic substitution reactions. The final compounds showed low cytotoxicity and several derivatives exerted antiviral activity against HCV or Dengue viruses at micromolar concentrations.
- 650 _2
- $a antitumorózní látky $x chemická syntéza $x farmakologie $7 D000970
- 650 _2
- $a antivirové látky $x chemická syntéza $x farmakologie $7 D000998
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a virus dengue $x účinky léků $7 D003716
- 650 _2
- $a Hepacivirus $x účinky léků $7 D016174
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prekurzory léčiv $x chemická syntéza $x farmakologie $7 D011355
- 650 _2
- $a purinové nukleosidy $x chemická syntéza $x farmakologie $7 D011684
- 650 _2
- $a purinové nukleotidy $x chemická syntéza $x farmakologie $7 D011685
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Caletková, Olga $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Perlíková, Pavla $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Poštová Slavětínská, Lenka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Tloušťová, Eva $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Hodek, Jan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Weber, Jan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic.
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic.
- 700 1_
- $a Hocek, Michal $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Flemingovo nam. 2, CZ-16610 Prague 6, Czech Republic; Department of Organic and Nuclear Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, CZ-12843 Prague 2, Czech Republic. Electronic address: hocek@uochb.cas.cz.
- 773 0_
- $w MED00000769 $t Bioorganic & medicinal chemistry $x 1464-3391 $g Roč. 23, č. 23 (2015), s. 7422-38
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26558518 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161021095929 $b ABA008
- 999 __
- $a ok $b bmc $g 1166284 $s 952600
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 23 $c 23 $d 7422-38 $e 20151031 $i 1464-3391 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
- LZP __
- $a Pubmed-20161005
